IDEAYA Biosciences, Inc.’s IDYA share price has surged by 10.70%, which has investors questioning if this is right time to sell.
8h
Zacks Investment Research on MSNGilead Sciences (GILD) Ascends But Remains Behind Market: Some Facts to NoteGilead Sciences (GILD) ended the recent trading session at $111.88, demonstrating a +0.54% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of ...
The Wadesboro Police Department is mourning the loss of K-9 Blitz, who died during a traffic stop incident that escalated ...
The Handmaid's Tale star Elisabeth Moss 's huge role in spin-off The Testaments has been unveiled. The new show acts as a ...
Highland cruised to a 12-2 win over visiting Pleasant on Tuesday, using a nine-run fourth inning to pull away from the Spartans.
As the sixth and final season of The Handmaid’s Tale is nearing its premiere next week, production on its sequel series The ...
Explore more
Next Tuesday, on April 8, Hulu will start airing the sixth and final season of The Handmaid's Tale, its adaptation of Margaret Atwood's 1985 dystopian novel...w ...
Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground ...
Hulu announced that it is developing a series based on Margaret Atwood's 2019 novel "The Testaments," which is a follow-up to ...
17h
Zacks Investment Research on MSNGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowGilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...
Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...
Bruce Miller knew for a long time how he wanted to bring the story to a conclusion,' says EP Eric Tuchman. 'It's about June's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results